PAK1 and inflammatory breast carcinoma: Only the 11q13.5 amplification in IBC did not overlap with non-IBC, which includes PAK1, an oncogene that activates MAPK and MET signalling and regulates cell motility; interestingly, previous reports have associated IBC with MAPK hyperactivation [50,51].